GSPAR

This brand name is authorized in Nigeria.

Active ingredients

The drug GSPAR contains one active pharmaceutical ingredient (API):

1	Sparfloxacin UNII Q90AGA787L - SPARFLOXACIN
	Sparfloxacin, an aminodifluoroquinolone, has in vitro activity against a wide range of gramnegative and gram-positive microorganisms. Sparfloxacin exerts its antibacterial activity by inhibiting DNA gyrase, a bacterial topoisomerase. In vitro tests show that the combination of sparfloxacin and rifampin is antagonistic against Staphylococcus aureus.

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-1073	Tablet	Gspar 200 Tablets TAB 200 mg	GSPAR 200 TABLETS A4-1073 GSPAR 200 TABLETS SPARFLOXACIN 200MG, MAIZE STARCH,MICRO CRYSTALLINE CELLULOSE,LACTOSE,PURIFIED WATER,MAGNESIUM STEARATE,TALCUM POWDER,SODOUM STARCH GLYCOLATE,FUMED SILICA,HYDROXYPROPYL METHYLCELLULOSE,TITANIUM DIOXIDE,POLYETHYLENE GLYCOL 4000,ISOPROPYL ALCOHOL, METHLYNE CHLORIDE,LAKE QUINOLINE YELLOW Tablet Prescription Only Medicine (POM) GREENLIFE PHARMACEUTICAL LIMITED, ASSOCIATION AVENUE, ILUPEJU LAGOS LAGOS Nigeria M/S MCW HEALTHCARE(P) LTD, 286, 287-A, 287-B, SECTOR-E, INDUSTRIAL AREA, SANWER ROAD, INDORE (M.P), INDIA, India 26/01/2023 25/01/2028	26/01/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA09	Sparfloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-1073